Cassava Sciences' Controversial Alzheimer's Drug Fails To Hit Primary Goal In Pivotal Study, Halts Late-Stage Studies
Cassava Sciences' stock fell after Phase 3 simufilam trial failed to meet key endpoints, prompting the discontinuation of its Alzheimer's studies.
Custom Helix eVTOL From Pivotal
Cutting-edge eVTOL for your own personal use Custom livery and all essentials included, like premium flight deck and 4K ...